- Home
- MLYS vs WB Comparison
MLYS vs WB Comparison
Compare MLYS & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | WB |
|---|---|---|
| Founded | 2019 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MLYS | WB |
|---|---|---|
| Price | $32.32 | $10.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $47.33 | $14.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 02-11-2026 | 11-18-2025 |
| Dividend Yield | N/A | ★ 15.26% |
| EPS Growth | N/A | ★ 20.16 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $1,740,785,000.00 |
| Revenue This Year | N/A | $0.53 |
| Revenue Next Year | N/A | $2.38 |
| P/E Ratio | ★ N/A | $6.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.24 | $7.10 |
| 52 Week High | $47.65 | $12.96 |
Technical Indicators
Market Signals| Indicator | MLYS | WB |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 54.37 |
| Support Level | $31.67 | $10.46 |
| Resistance Level | $33.64 | $11.22 |
| Average True Range (ATR) | 1.67 | 0.25 |
| MACD | -0.23 | 0.05 |
| Stochastic Oscillator | 19.56 | 58.59 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.